This is the first competing continuation application for the Vanderbilt Clinical Oncology Research Career Development Program (VCORCDP). The goals and objectives of the program remain unchanged from our original proposal: to train physicians for careers in academic-oriented, clinical oncology therapeutic research. The VCORCDP was originally designed to include three oncology disciplines and recruited candidates from fourth and fifth year surgical residents and second and third year fellows in pediatric or medical oncology/hematology. Based in part to the great success of the K12 sponsored training program, and in light of the decision to submit a recent NCI training grant to support the Division of Hematology and Oncology junior-level fellows, we are requesting support to restructure and expand the K12 VCORCDP to include senior level fellows and/or junior faculty candidates from four existing Vanderbilt oncology disciplines: (1) Adult Hematology and Oncology, (2) General Surgery/Surgical Oncology, (3) Pediatric Hematology and Oncology, and (4) Radiation Oncology. Trainees will participate in a comprehensive, didactic lecture series which focuses on the important aspects of clinical research (20% time commitment). All trainees will also participate in a mentored, patient-oriented, hypothesis-driven clinical research project which exposes them to Vanderbilt's extensive multidisciplinary research community (80% time commitment). Trainees are supported for a minimum of two years and research projects involve multiple mentors with both clinical and laboratory research experiences. The proposed training program faculty consists of thirty-eight mentors who are experienced clinical investigators or basic scientists within the Vanderbilt-lngram Cancer Center. All of the proposed faculty mentors have peer-reviewed research support directly related to cancer as well as a proven track record in mentoring fellows and junior faculty in an academic environment. Trainees successfully completing the two-year didactic lectures and patient-oriented research will be awarded a Master of Science in Clinical Investigation degree fromj Vanderbilt. Support is being requested for three training positions per year. The health and medical care system is creating an environment that places greater priority and demand on well-designed clinical trials. Cost-effective therapies, novel treatments and new diagnostic procedures need to be evaluated while ensuring patient safety and quality assurance. However, there are a number of obstacles limiting our ability to succeed in this area including a significant national concern regarding the shortage of physicians who choose academic careers in clinical research. The Vanderbilt-lngram Cancer Center is in a strong position to provide a strong training experience within a rich research environment, both of which are critical factors in determining successful careers in cancer research. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12CA090625-08
Application #
7486196
Study Section
Special Emphasis Panel (ZCA1-RTRB-L (J1))
Program Officer
Lei, Ming
Project Start
2001-09-21
Project End
2011-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
8
Fiscal Year
2008
Total Cost
$583,083
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Iams, Wade T; Beckermann, Kathryn E; Almodovar, Karinna et al. (2018) Small cell lung cancer transformation as a mechanism of resistance to PD-1 therapy in KRAS mutant lung adenocarcinoma: A report of two cases. J Thorac Oncol :
Tadros, Joseph; Goodman, Stacey; Tkaczyk, Eric R (2018) Subcutaneous scalp nodule as the presenting symptom of systemic light-chain amyloidosis. Dermatol Pract Concept 8:184-187
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Shinall Jr, Myrick C; Martin, Sara F; Nelson, Jill et al. (2018) Five-Year Experience of an Inpatient Palliative Care Unit at an Academic Referral Center. Am J Hosp Palliat Care 35:1057-1062
Earl, David C; Ferrell Jr, P Brent; Leelatian, Nalin et al. (2018) Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics. Nat Commun 9:39
Iams, Wade T; Lovly, Christine M (2018) Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived. Cancer Discov 8:797-799
Shinall Jr, Myrick C; Ehrenfeld, Jesse M; Gunter Jr, Oliver L (2018) Nonoperative Management of Perforated Hollow Viscera in a Palliative Care Unit. Ann Surg 268:e1-e3
Ricketts, Christopher J; De Cubas, Aguirre A; Fan, Huihui et al. (2018) The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23:313-326.e5
Miettinen, Teemu P; Peltier, Julien; Härtlova, Anetta et al. (2018) Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib. EMBO J 37:
Martin, Donna M; Rathmell, W Kimryn; Tavazoie, Sohail F (2018) Balancing dual demands on the physician-scientist workforce. J Clin Invest 128:3204-3205

Showing the most recent 10 out of 204 publications